Evidence map›Paper›PMID 34834479›Full record

ArticleJournal of personalized medicine2021

Optimized Prediction Models from Fundus Imaging and Genetics for Late Age-Related Macular Degeneration.

Arun Govindaiah, Abdul Baten, R Theodore Smith, Siva Balasubramanian, Alauddin Bhuiyan

Open access · goldAbstract read
In one paragraph

Article in Journal of personalized medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Arun GovindaiahiHealthscreen Inc., New York, NY 11418, USA.ORCID 0000-0001-7458-5361
Abdul BatenAgResearch, Palmerston North 4442, New Zealand.
R Theodore SmithNew York Eye and Ear Infirmary, New York, NY 10003, USA.ORCID 0000-0002-1693-943X
Siva BalasubramanianGenetech, South San Francisco, CA 94080, USA.
Alauddin BhuiyaniHealthscreen Inc., New York, NY 11418, USA.
EcoHealth Alliance · USAgResearch · NZNew York Eye and Ear Infirmary · US

Funding

A Model for Predicting 2-Year Risk of Incident Late Age-related Macular DegenerationR44EY031202 · NEI · IHEALTHSCREEN, INC. · PI Alauddin Bhuiyan, Roland THEODORE SMITH · 2020 to 2026
$4.3M
NEI NIH HHS EY031202NEI NIH HHS R44 EY031202
6 · The paper itself

Abstract

Age-related macular degeneration (AMD) is a leading cause of blindness in the developed world. In this study, we compare the performance of retinal fundus images and genetic-information-based machine learning models for the prediction of late AMD. Using data from the Age-related Eye Disease Study, we built machine learning models with various combinations of genetic, socio-demographic/clinical, and retinal image data to predict late AMD using its severity and category in a single visit, in 2, 5, and 10 years. We compared their performance in sensitivity, specificity, accuracy, and unweighted kappa. The 2-year model based on retinal image and socio-demographic (S-D) parameters achieved a sensitivity of 91.34%, specificity of 84.49% while the same for genetic and S-D-parameters-based model was 79.79% and 66.84%. For the 5-year model, the retinal image and S-D-parameters-based model also outperformed the genetic and S-D parameters-based model. The two 10-year models achieved similar sensitivities of 74.24% and 75.79%, respectively, but the retinal image and S-D-parameters-based model was otherwise superior. The retinal-image-based models were not further improved by adding genetic data. Retinal imaging and S-D data can build an excellent machine learning predictor of developing late AMD over 2-5 years; the retinal imaging model appears to be the preferred prognostic tool for efficient patient management.

Indexed as

deep learningfundus imaginggeneticsmacular degeneration

Identifiers

PMID34834479
PMCPMC8617775
OpenAlexW3209892765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.